Establishment Labs Announces Participation in Upcoming Investment Conferences
Establishment Labs Holdings (NASDAQ: ESTA), a medical technology company focused on women's health and breast aesthetics, announced its participation in three upcoming investment conferences in November 2024. CEO Juan José Chacón-Quirós and CFO Raj Denhoy will attend the UBS Global Healthcare Conference, while Chacón-Quirós will present at the Jefferies London Healthcare Conference, and Denhoy at the Stephens Annual Investment Conference. Live webcasts of all presentations will be available on the company's investor relations website.
Establishment Labs Holdings (NASDAQ: ESTA), un'azienda di tecnologia medica focalizzata sulla salute delle donne e sull'estetica del seno, ha annunciato la sua partecipazione a tre conferenze di investimento previste per novembre 2024. Il CEO Juan José Chacón-Quirós e il CFO Raj Denhoy parteciperanno alla UBS Global Healthcare Conference, mentre Chacón-Quirós presenterà alla Jefferies London Healthcare Conference e Denhoy alla Stephens Annual Investment Conference. Le dirette web di tutte le presentazioni saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda.
Establishment Labs Holdings (NASDAQ: ESTA), una compañía de tecnología médica centrada en la salud de la mujer y la estética mamaria, anunció su participación en tres próximas conferencias de inversión en noviembre de 2024. El CEO Juan José Chacón-Quirós y el CFO Raj Denhoy asistirán a la UBS Global Healthcare Conference, mientras que Chacón-Quirós presentará en la Jefferies London Healthcare Conference y Denhoy en la Stephens Annual Investment Conference. Las transmisiones en vivo de todas las presentaciones estarán disponibles en el sitio web de relaciones con inversores de la compañía.
Establishment Labs Holdings (NASDAQ: ESTA), 여성 건강 및 유방 미용에 초점을 맞춘 의료 기술 회사는 2024년 11월에 열리는 세 개의 투자 회의에 참여할 것이라고 발표했습니다. CEO 후안 호세 차곤-키로스 및 CFO 라지 덴호이가 UBS 글로벌 헬스케어 컨퍼런스에 참석하며, 차곤-키로스는 제퍼리스 런던 헬스케어 컨퍼런스에서 발표하고 덴호이는 스티븐스 연례 투자 컨퍼런스에 참석합니다. 모든 발표의 생중계는 회사의 투자자 관계 웹사이트에서 확인할 수 있습니다.
Establishment Labs Holdings (NASDAQ: ESTA), une entreprise de technologie médicale axée sur la santé des femmes et l'esthétique mammaire, a annoncé sa participation à trois conférences d'investissement à venir en novembre 2024. Le PDG Juan José Chacón-Quirós et le directeur financier Raj Denhoy assisteront à la UBS Global Healthcare Conference, tandis que Chacón-Quirós présentera lors de la Jefferies London Healthcare Conference et Denhoy lors de la Stephens Annual Investment Conference. Des diffusions en direct de toutes les présentations seront disponibles sur le site web des relations investisseurs de l'entreprise.
Establishment Labs Holdings (NASDAQ: ESTA), ein Medizintechnikunternehmen, das sich auf die Gesundheit von Frauen und Brustästhetik konzentriert, gab seine Teilnahme an drei bevorstehenden Investorenkonferenzen im November 2024 bekannt. CEO Juan José Chacón-Quirós und CFO Raj Denhoy werden an der UBS Global Healthcare Conference teilnehmen, während Chacón-Quirós auf der Jefferies London Healthcare Conference präsentieren und Denhoy auf der Stephens Annual Investment Conference sprechen wird. Live-Webcasts aller Präsentationen werden auf der Website der Investorenbeziehungen des Unternehmens verfügbar sein.
- None.
- None.
Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Chief Financial Officer, will participate in the 2024 UBS Global Healthcare Conference being held November 11-14, 2024. Mr. Chacón-Quirós and Mr. Denhoy are scheduled to speak to conference attendees on Tuesday, November 12 at 2:00-2:35 PM PST.
Mr. Chacón-Quirós will participate in the 2024 Jefferies London Healthcare Conference held November 19-21, 2024. Mr. Chacón-Quirós is scheduled to speak in person to conference attendees on Wednesday, November 20 at 7:30-7:55 AM GMT.
Mr. Denhoy will participate in the 2024 Stephens Annual Investment Conference, being held on November 19-21, 2024. Mr. Denhoy is scheduled to speak in person to conference attendees on Thursday, November 21 at 12:00-12:45 PM CST.
Live webcasts of the presentations will be available to all interested parties on the Establishment Labs investor relations website at https://investors.establishmentlabs.com/. Archived versions of the webcasts will be available on the same website following the completion of the events.
About Establishment Labs
Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The nearly four million Motiva® devices Establishment Labs has delivered to plastic and reconstructive surgeons since 2010 have created a new standard for safety and patient satisfaction in the over 85 countries in which they are available. The Motiva Flora® tissue expander is used to improve outcomes in breast reconstruction following breast cancer and it is the only regulatory-approved expander in the world with an integrated port using radio-frequency technology that is MRI conditional. Mia Femtech™, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 20 separate patent families worldwide and over 100 scientific and clinical studies and publications in peer reviewed journals. Establishment Labs manufactures at two facilities in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111618470/en/
Investor/Media Contact:
Raj Denhoy
415 828-1044
rdenhoy@establishmentlabs.com
Source: Establishment Labs Holdings Inc.
FAQ
When will Establishment Labs (ESTA) present at the 2024 UBS Global Healthcare Conference?
Which investment conferences will Establishment Labs (ESTA) attend in November 2024?
Where can investors watch Establishment Labs' (ESTA) conference presentations?
